Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (141-150 of 415) with videos related to

Pageof 42
Sort By:
Frontiers in Medicine|August 6, 2021
Network Analysis of Outpatients to Identify Predictive Symptoms and Combinations of Symptoms Associated With Positive/Negative SARS-CoV-2 Nasopharyngeal SwabsHervé Spechbach, Frédérique Jacquerioz, Virginie Prendki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 8, 2015
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular EventsGilles Wandeler, David Kraus, Jan Fehr, et al.
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Antiretroviral therapy]Amrei von Braun, Hansjakob Furrer, Manuel Battegay, et al.
Plos One|December 25, 2013
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcomeMaryline Bonnet, Elisabeth Baudin, Ilesh V Jani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2025
Late Re-Engagement Into HIV Care Among Adults in the Swiss HIV Cohort StudyAndreas D Haas, Katharina Kusejko, Matthias Cavassini, et al.
HIV Medicine|June 9, 2025
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility surveyMarie Ballif, Manuela Correia da Silva Saúde, David Haerry, et al.
AIDS (London, England)|July 27, 2017
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSMNello Blaser, Barbara Bertisch, Roger D Kouyos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort AnalysisDami Collier, Collins Iwuji, Anne Derache, et al.
Journal of the American College of Cardiology|April 3, 2020
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK StudyFranck Boccara, Princy N Kumar, Bruno Caramelli, et al.
AIDS (London, England)|November 16, 2012
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientKuntheavy I Lorenzini, Alexandra Calmy, Juan Ambrosioni, et al.
Pageof 42

Showing results (141-150 of 415) with videos related to

Sort By:
Pageof 42
Frontiers in Medicine|August 6, 2021
Network Analysis of Outpatients to Identify Predictive Symptoms and Combinations of Symptoms Associated With Positive/Negative SARS-CoV-2 Nasopharyngeal SwabsHervé Spechbach, Frédérique Jacquerioz, Virginie Prendki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 8, 2015
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular EventsGilles Wandeler, David Kraus, Jan Fehr, et al.
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Antiretroviral therapy]Amrei von Braun, Hansjakob Furrer, Manuel Battegay, et al.
Plos One|December 25, 2013
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcomeMaryline Bonnet, Elisabeth Baudin, Ilesh V Jani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2025
Late Re-Engagement Into HIV Care Among Adults in the Swiss HIV Cohort StudyAndreas D Haas, Katharina Kusejko, Matthias Cavassini, et al.
HIV Medicine|June 9, 2025
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility surveyMarie Ballif, Manuela Correia da Silva Saúde, David Haerry, et al.
AIDS (London, England)|July 27, 2017
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSMNello Blaser, Barbara Bertisch, Roger D Kouyos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort AnalysisDami Collier, Collins Iwuji, Anne Derache, et al.
Journal of the American College of Cardiology|April 3, 2020
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK StudyFranck Boccara, Princy N Kumar, Bruno Caramelli, et al.
AIDS (London, England)|November 16, 2012
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientKuntheavy I Lorenzini, Alexandra Calmy, Juan Ambrosioni, et al.
Pageof 42